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Abstract
Amyloid-b (Ab) peptide aggregation is known to play a central role in the etiology of Alzheimer’s disease (AD). Among
various aggregates, low-molecular weight soluble oligomers of Ab are increasingly believed to be the primary neurotoxic
agents responsible for memory impairment. Anionic interfaces are known to influence the Ab aggregation process
significantly. Here, we report the effects of interfaces formed by medium-chain (C9–C12), saturated non-esterified fatty acids
(NEFAs) on Ab42 aggregation. NEFAs uniquely affected Ab42 aggregation rates that depended on both the ratio of Ab:NEFA
as well the critical micelle concentration (CMC) of the NEFAs. More importantly, irrespective of the kind of NEFA used, we
observed that two distinct oligomers, 12–18 mers and 4–5 mers were formed via different pathway of aggregation under
specific experimental conditions: (i) 12–18 mers were generated near the CMC in which NEFAs augment the rate of Ab42
aggregation towards fibril formation, and, (ii) 4–5 mers were formed above the CMC, where NEFAs inhibit fibril formation.
The data indicated that both 12–18 mers and 4–5 mers are formed along an alternate pathway called ‘off-pathway’ that did
not result in fibril formation and yet have subtle structural and morphological differences that distinguish their bulk
molecular behavior. These observations, (i) reflect the possible mechanism of Ab aggregation in physiological lipid-rich
environments, and (ii) reiterate the fact that all oligomeric forms of Ab need not be obligatory intermediates of the fibril
formation pathway.
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Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder that leads to cognitive decline and memory impairment.
As in many other neurodegenerative diseases, AD is one in which
polypeptides form amyloid deposits. Brains of patients with AD
have large proteinacious deposits known as senile plaques. The
proteinacious core of these extracellular deposits is mainly
composed of 40- and 42-residue peptides (Ab40 and Ab42,
respectively), collectively called Ab peptides. According to the
early amyloid hypothesis, fibrillar Ab was thought to be largely
responsible for the neuronal dysfunction and cognitive decline in
patients with AD [1]. However, the degree of cognitive
impairment did not correlate well with the amount of plaque
deposits prior to death in some AD patients [2,3], while
correlations between soluble Ab levels and the extent of synaptic
loss and cognitive impairment were more pronounced [4,5]. This
has led to the shift in focus towards smaller oligomeric
intermediates in the aggregation pathway that may be responsible
for toxicity. Specifically, smaller, low-molecular weight oligomers
have been the most scrutinized as several reports have implicated
them in neuronal toxicity and synaptic dysfunction. Consequently,
several oligomeric species ranging between 2 and 12 mers were
identified in the cerebrospinal fluid (CSF) of AD patients [5], in
transgenic mouse models that express the APP variant linked to
AD [6–8] and in neuronal cell cultures [9].
In the context of soluble oligomers, interfacial aggregation of Ab
in the presence of anionic surfactants, such as lipids, fatty acids and
surfactants seem to play significant roles. Several reports demon-
strated the effects of anionic phospholipids on Ab aggregation and
showedthat theinteraction ofAb withlipidsis restricted tothepolar
head groups [10–12]. In addition, GM1 ganglioside containing
membranes have been shown to promote Ab aggregation in vitro
[13–18]. Similarly, polyunsaturated (PUFAs) as well as saturated
fatty acids arealsoknown to have significant effects on the AD brain
[19,20]. More importantly, these interfaces play unique roles in
generating oligomeric forms of Ab. In the presence of GM1
containing liposomes Ab40 generated oligomers that were able to
act as exogenous ‘seed’ in the Alzheimer’s brain [21,22]. In
addition, lipid rafts isolated from the brain tissues induced the
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18759formation of 4 mers of Ab that did not convert to fibrils for
prolonged periods of time [23], suggesting increased turnover time
for these lipid-induced oligomers. A variety of physiological and
non-physiological interfaces are known to influence Ab aggregation
and generation of oligomeric species [24–26].
One surfactant that is known to play a significant role in this
regard is sodium dodecylsulphate (SDS), a commonly known
detergent used for denaturing protein structures. SDS has also
been demonstrated to affect the aggregation of other amyloid
proteins such as b2 microglobulin and a-synuclein [27,28], besides
Ab. Anionic micelles generated by SDS form good interface
models and are observed to accelerate both Ab40 and Ab42
aggregation over a limited concentration range [29]. In particular,
at concentrations just below its critical micelle concentration
(CMC), SDS was able to promote the formation of 2–4 mers and
8–12 mers of Ab42, but did not promote the formation of similar
oligomers with Ab40 [30,31]. However, at concentrations well
below the CMC, SDS augmented Ab42 fibril formation rates and
failed to generate oligomers. Furthermore, the 2–4 mers and 8–
12 mers seemed to form from a pathway that was different from
the one resulting in fibril formation described by Rangachari et al
[30]. Interestingly, aggregates from both pathways showed a b-
sheet conformation but differed in their ThT binding capability
and morphology. Prior to this observation, Barghorn and
colleagues also generated 38–48 kDa (8–12 mer) Ab42 oligomers,
called ‘globulomers,’ by co-incubating Ab42 in low concentrations
of SDS [32]. These exogenous globulomers were toxic and
inhibited LTP in human brain slices. More importantly, the
globulomers also formed independently from the fibril formation
pathway, suggesting an alternate pathway induced by SDS
interfaces [33]. Based on these previous reports, it is clear that
by choosing appropriate concentrations of SDS as well as the SDS:
Ab42 ratio, one can induce different pathways of Ab42
aggregation. Although SDS is a good model system to mimic
anionic lipid interfaces, it is not a physiological component and
hence ambiguity would remain about the significance of its
interaction with Ab. Therefore, there is a need to explore whether
physiological lipids and fatty acids can dictate similar multiple
pathways of Ab aggregation and generate stable oligomers. Given
the structural similarity to SDS and possible contribution to other
forms of human amyloidosis[34,35], non-esterified fatty acids
(NEFAs) are important candidates for exploration of their effects
on Ab aggregation. NEFAs are produced de novo by adipocytes or
lipolysis of plasma triacylglycerol in chylomicrons or very-low
density lipoproteins, transported by serum albumin, and incorpo-
rated in adipocytes or muscle cells [36]. NEFAs are also abundant
in both cerebral vasculature as well as in the CSF [37,38], and in
the brain, long-chain NEFAs (C12–C26) are abundant.
Here, we report the effects of saturated NEFAs on Ab42
aggregation and pathways mainly to simulate Ab-NEFA interac-
tion under physiological conditions. These studies employed
medium-chain saturated NEFAs as a model system to circumvent
a solubility problem associated with long-chain NEFAs. In
addition, the CMCs of long-chain fatty acids (C18–C22) are
much lower (,mM–nM) than those of their medium-chain
counterparts (C9–C14; ,mM), their interactions with Ab at nM
– pM physiological concentration range can be conveniently
reproduced and examined by using medium-chain NEFAs and
mM concentrations of Ab in vitro. Thus, we have used fatty acids of
varying carbon chain lengths including pelargonic acid (C9),
capric acid (C10), undecylic acid (C11), and lauric acid (C12) to
see how the CMC and Ab : fatty acid ratios affect the overall
aggregation process, particularly in dictating multiple pathways.
The results indicate a fundamentally important phenomenon that
has largely been overlooked, which may be a critical factor in AD
pathogenesis.
Results
Determination of the critical micelle concentrations
(CMCs) of saturated NEFAs
In this study, we have chosen medium-chain saturated NEFAs
of varying carbon lengths including C9 C10, C11, and C12
(Figure 1A) to examine their effects on Ab42 aggregation. Phase
Figure 1. Critical micelle concentration (CMC) measurements of
NEFAs used in this study. A) NEFAs used in this study: ‘n’ represents
the carbon chain length, B) N-phenyl-1- naphthylamine (NPN)
fluorescence response curves for fatty acids used in this study; C9
(#), C10 (m), C11 (,) & C12 (¤ ). Representative dotted lines for C9
shows the linear extrapolations of the curve to calculate CMC, which is
the point of intersection ; C) CMC of fatty acids determined by these
measurements plotted as a function of carbon chain length.
doi:10.1371/journal.pone.0018759.g001
‘Off-Pathway’ Ab42 Oligomers
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widely investigated in the past and it is well known that sodium
salts of NEFAs exhibit by and large a two phase behavior; above
and below their CMCs [39–43]. However, more complicated
phase behavior was observed as a function of ionization state of
NEFAs and pH [44]. Nevertheless, at a given set of pH and buffer
conditions, the presence of the two broadly-defined micellar and
non-micellar phases have been well documented previously [39–
43]. In order to determine the respective CMCs of NEFAs in the
buffer (10 mM Tris-HCl, 50 mM NaCl, pH 8.0) used in the study,
we used N-phenyl-1-naphthylamine (NPN) as a probe that
fluoresces upon binding to micelles, as reported earlier [40,45].
Figure 1B shows the normalized fluorescence titration curves for
varying concentrations of NEFAs. The first ‘inflection point’
(indicated by extrapolated dotted lines for C9 in Figure 1B) that
occurs upon increasing the fatty acid concentration was considered
to be the CMC. Figure 1C shows the plot of CMCs determined
from Figure 1B as a function of increasing carbon chain length.
The estimates of CMCs obtained were in agreement with previous
reports [40,41]. The presence of micelles above the CMCs was
also confirmed by dynamic light scattering analyses, whose size
varied with carbon chain length (data not shown).
Effect of saturated NEFAs on Ab42 aggregation
The aggregation kinetics of Ab42 in the presence of NEFAs of
varying carbon chain lengths, C9, C10, C11 and C12, was
monitored by ThT fluorescence as shown in Figure 2A–D. To
assess the effect of CMC of fatty acids on Ab42 aggregation, based
on previous reports on Ab interactions with SDS and other
surfactants [30] we chose three specific concentrations of fatty
Figure 2. Dependence of Ab42 aggregation on fatty acid concentration monitored by ThT fluorescence. Monomeric Ab42 (25 mM) was
incubated at 37uC in buffer alone (C; &) or with varying concentrations of fatty acids C9 (A), C10 (B), C11 (C) and C12 (D), above (,), below (#)o r
near (m) their respective CMCs. The numbers indicated inside the boxes are respective concentrations of fatty acids in mM units. The data are
averages of three experiments with different Ab42 purification batches. The data were fit with Eq 1; E) Western blots of the samples in A–D probed
using monoclonal antibody, Ab9 after 128 h of incubation. The samples were run on a 12% bis-Tris acrylamide gels with Laemmli buffer. Double
arrow indicates 4–5 mers while the triple arrow indicates 12–18 mers of Ab42. ‘M’ represents the monomer control while ‘C’ represents Ab42 sample
in the absence of fatty acids. The numbers on top of the gels are fatty acid concentrations in mM units.
doi:10.1371/journal.pone.0018759.g002
‘Off-Pathway’ Ab42 Oligomers
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CMC. Incubation of 25 mM buffered (10 mM Tris, 50 mM NaCl,
pH 8.0) Ab42 alone at 37uC showed a typical sigmoidal pattern
with a lag-time of,57 h (Figure 2A–D, control) indicating the
growth of fibrils. However, upon incubation with varying
concentrations of fatty acids, three different types of aggregation
behavior were observed. For concentrations of fatty acids well
below their CMC, the rate of Ab42 aggregation is similar to that of
the control. For concentrations of fatty acids near their CMC, the
rate of aggregation is significantly accelerated, and for concentra-
tions well above the CMC aggregation is inhibited. This is clearly
seen in Figure 2A for the C9 solutions, where concentrations of C9
near the CMC (100 mM) augmented the rate of Ab42 aggregation
with no observable lag-time, while in concentrations well above
CMC (300 mM), the co-incubated sample failed to show
significant ThT fluorescence over the 10-day incubation period.
Incubations with concentration below the C9 CMC (20 mM), did
not show any significant difference from the control sample in the
absence of fatty acids. We observed that this phenomenon of
increase and decrease in Ab aggregation rates at near and well
above the CMC respectively, is conserved for all fatty acids that
were analyzed. Increased rates of Ab42 aggregation were observed
in incubations with 50 mM C10, 20 mM C11 and 5 mM C12 (m
in Figures 2B, C and D respectively) concentrations that are near
their respective CMCs. Similarly, Ab42 incubations with concen-
trations above the CMCs (150 mM C10, 75 mM C11 and 20 mM
C12) resulted in very low ThT fluorescence levels suggesting lack
of aggregation (, in Figure 2B, C and D). Furthermore, the
concentrations of fatty acids well below their CMCs did not have
any significant effect on Ab42 aggregation for all fatty acids
observed (# in Figure 2B, C and D). Appropriate blanks of ThT
as well as bis-ANS fluorescent probes in 20 mM C12 fatty acid
alone did not show significant increase in fluorescence intensity
suggesting that the micelles do not interact with the probes to
contribute significantly to the intensity observed.
Since the interfaces generated by micellar SDS have been
previously observed to generate specific oligomeric Ab42 species
[30], we wanted to establish whether similar oligomeric forms are
generated by NEFAs also. Therefore, aliquots of the samples after
130 h of incubation from the reactions in Figure 2A–D were
subjected to SDS-PAGE analysis and immunoblotting using Ab9
monoclonal antibody as shown in Figure 2E. All samples were
subjected to electrophoresis on a 12% bis-Tris acrylamide gels
with Laemmli buffer. In an effort to resolve potential dimeric
band that may be present, we attempted several runs on 4–12%
NuPageH gels (Invitroen Inc). However, the presence of high
concentrations of NEFAs (particularly in C9, C10 and C11 cases)
obscured the banding patterns (data not shown). Nevertheless, in
12% gels, the control Ab42 in the absence of fatty acid showed a
monomeric band along with one that failed to enter the gel (band
on the top of the gel), indicating the formation of fibrils as also
observed by ThT fluorescence (Figure 2E, lane 2). Fatty acid
concentrations well below the CMC that did not have significant
effect on aggregation as observed by ThT fluorescence indicated
a banding pattern that was similar to the control sample
(Figure 2E; lanes 3, 6, 9 & 12). In sharp contrast, solutions
incubated with fatty acid concentration near and well above
CMC showed differences in the banding patterns. At fatty acid
concentrations near their respective CMCs where aggregation
rates were augmented, the samples showed a predominant 50–
80 kDa band that corresponded to 12–18 mers of Ab42 (lanes 4,
7, 10 & 13; indicated by triple arrows). In addition, a faint band
at 20 kDa (5 mer; indicated by double arrows) along with fibrillar
(F) and monomeric bands were observed (Figure 2E). Monomeric
bands were observed in almost all samples, and it is likely that this
is due in part to partial dissociation of higher molecular weight
aggregates upon exposure to high concentrations of SDS during
electrophoresis. Similarly, it is also reasonable to hypothesize that
the faint 4–5 mer bands seen along with 12–18 mer bands may
arise from partial dissociation of these oligomers. Nevertheless, at
concentrations well above their respective CMCs where samples
failed to show significant ThT levels, the presence of fatty acids
resulted in a predominant 16–20 kDa band corresponding to 4–
5 mers of Ab42, in addition to a monomeric band (lanes 5, 8, 11
& 14). Similar band patterns were observed at approximately
220 h of incubation also (data not shown). Overall the data
indicate that fatty acid concentrations above and near the CMC
lead to show maximum differences in the aggregation rates and
generate predominantly two distinct oligomeric species of Ab42:
12–18 mers and 4–5 mers.
Secondary structure changes during aggregation
suggest subtle secondary structure differences between
12–18 mers and 4–5 mers
In order to gain insights into the secondary structure changes in
Ab42 that occur during aggregation in the presence of different
concentrations of fatty acids, we analyzed the samples using far-
UV CD spectroscopy. Aliquots of samples incubated under
identical conditions as those shown in Figure 2 were analyzed
and data were collected using a CD spectropolarimeter every day
for 10 days. The spectra for three specific time points, 0, 48 and
240 h, are shown in Figure 3. As expected, the control Ab42 in the
absence of fatty acids displayed a random coil conformation at 0 h
that converted to a b-sheet over a 10-day incubation period with a
negative minimum at approximately 216 nm, suggesting conver-
sion into fibrils (Figure 3A). For the samples incubated with fatty
acids, based on ThT and immunoblot results, we chose
concentrations, near and above the respective CMCs, to examine
by CD. All Ab42 solutions containing the fatty acids, C9–C12, at
both near- and above-CMC concentrations showed immediate
conformational change from a random coil monomer. The
resulting Ab42/NEFAs CD spectra exhibited similar general
features, with a minimum at approximately 216 nm, indicative of
a predominantly b-sheet conformation (Figure 3B-I). The
sharpness and amplitude of that feature, differed only subtly for
near- and above-CMC NEFA conditions. This may be attributed
to differences in relative contributions of the parallel and
antiparallel b-sheets, and potential contributions from turn
conformations, for example b-turn type I [46–48]. Incubations
at NEFA concentration below CMC resulted in similar behavior
to control samples with the conversion of random coil to b-sheet
over the incubation period (Figure S1).
Unfortunately, data could not be collected below l=210 nm
for the 300 mM C9 solution as the high concentration of the fatty
acid resulted in prohibitively high absorbance of the sample.
Collectively, the CD data suggest that both the 12–18 mers and
the 4–5 mers are predominantly b-sheet, but they appear to
contain subtle differences in their secondary structures. It also
appears that there is an overall shift towards higher b-sheet
structure for Ab42 samples in the presence of NEFAs above the
CMC as compared to the ones with near CMC. Based on this
difference one may speculate that the contributions from
conformational change in monomeric Ab might contribute to
the spectra in addition to the relative populations of 4–5 mer/12–
18 mers. It is also noteworthy that b-sheet structures formed by 4–
5 mers do not exhibit ThT fluorescence, unlike those formed by
12–18 mers.
‘Off-Pathway’ Ab42 Oligomers
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18759Figure 3. Secondary structure change indicated by far-UV CD during incubation of Ab42 with varying concentrations of NEFAs, C9,
C10, C11 and C12 near (left panel) or above (right panel) their respective CMCs.
doi:10.1371/journal.pone.0018759.g003
‘Off-Pathway’ Ab42 Oligomers
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morphologies
The morphologies of the structures generated in solutions with
different concentrations of fatty acids were examined by AFM.
Aliquots of samples taken after 240 h of incubation from Ab42
solutions containing fatty acid concentrations near and above the
CMC were deposited on freshly cleaved mica surfaces as described in
the experimental section, dried and imaged in AFM tapping mode
(Figure 4). Clear differences in the morphologies of the samples taken
from the different fatty acid solution concentrations were observed.
The control Ab42 sample showed clusters of fibrillar material across
the entire mica surface (Figure 4A). Images of samples taken from
solutions with fatty acid concentration near the CMC exhibited
mixtures of fibrillar and smaller rounded/oblong shaped features
dispersed across the mica surface (Figures 4 B,D,F,H), while those
taken from solutions above CMC revealed only rounded/oblong
features (Figures 4 C,E,G,I). The AFM analysis correspondswell with
the results obtained from SDS-PAGE, where it was shown that the
fatty acid solutions near CMC generated predominantly 12–18 mers
and fibrils, with smaller amounts of 4–5 mers, while those above
CMC generated 4–5 mers and no fibrils (Figure 2E). Analysis of the
height profiles of the AFM surfaces revealed that the majority of the
features had cross-sectional heights of 6–8 nm. Measured average
cross-sectional height of the fibrils in the control sample was
6.160.8 nm. The small rounded/oblong features in the samples
prepared from near CMC fatty acid concentration showed average
height of 7.962.9, while the fibrillar features showed average height
of 5.661.3 (Figure 4 B,D,F,H). The oblong features in the samples
produced from high concentration of fatty acid had average height of
6.761.0 nm (Figure 4 C,E,G,I). The small percentage of large,
irregular globular features observed in some of the samples presented
heights ranging from 12 to 20 nm. We attribute these larger globules
to aggregates of oligomers. Thus, the heights of the features are
generally similar in allsamples, but the aspect ratio varies with NEFA
concentration. For example, fibrils, circular structures and short
elongated structures are clearlyseen inFigure 4 D. Nosuchelongated
or fibrillar structures are visible in solutions with high fatty acid
concentrations. Collectively, the AFM data suggest that the structures
generated by near CMC concentrations (predominantly 12–18 mers
with some fibrils) are morphologically different from those generated
in high concentrations of fatty acids (predominantly 4–5 mers).
Seeding experiments suggest 12–18 mers and 4–5 mers
may have structural dissimilarities
Results from ThT fluorescence, immunoblotting, CD spectros-
copy and AFM experiments suggested that 12–18 mers and 4–
5 mers may have fundamentally different structures and morphol-
ogies. It is well known that the Ab aggregation is a nucleation
dependent process and that the lag phase of aggregation can be
eliminated by adding preformed aggregates as ‘seeds’ to monomeric
Ab42 [49]. The structure and morphology of the seeded aggregates
as well as the efficiency of seeding, which directly reflects the
elongation rates, depends on the structure of the ‘seed’ itself [50]. In
other words, if the oligomers formed are structurally compatible
with the emerging structure of fibrils, they will seed the on-pathway
fibril formation process. Thus, the seeding process is one way of
evaluating the structural assembly of oligomers and consequently
pathways of aggregation as reported previously [50–54].
For this experiment, we incubated ‘seed-free’ monomeric Ab42
(purified by SEC, see Experimental Procedures), with fatty acids
(C9–C12) at concentrations near and above their respective CMCs
under similar conditions as those described for Figure 2. After 48 h
of incubation aliquots of the samples were electrophoresed and
immunoblotted to evaluate the formation of oligomeric species. As
expected, the samples indicated the presence of 12–18 mers in
concentrations near, and 4–5 mers at concentrations above the
Figure 4. Aliquots of the samples from Figure 2 were probed to
see the morphologies of Ab42 aggregates generated in the
presence of varying concentrations of fatty acids either near or
above the CMC by atomic force microscopy (AFM). A) control ;
B&C) 100& 300 mM C9;D & E) 50 & 150 mM C10; F & G) 20 & 75 mM C11;
H & I) 5 & 20 mM C12. Amplitude images with scale of 0–0.4 volts are
presented. The white arrows indicate typical oligomeric samples. The
white scale bar represents 1 mm and each square represents 565 mm
field and the inset shows a different field of dimensions 161 mm.
doi:10.1371/journal.pone.0018759.g004
‘Off-Pathway’ Ab42 Oligomers
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are no other bands in between monomer and 4–5 mers, we
electrophoresed Ab42 samples incubated in C12 on a 4–12%
NuPage gels (lanes 3 and 4, Figure 5B). We have also included
similar Ab42 incubation in 2 mM SDS as a positive control (lane
5, Figure 5B) [30]. We did not see any discrete bands in between
monomeric and 4–5 mer bands in any of the samples. In parallel,
10% (v/v) aliquots of the samples were used as ‘seeds’ by adding
them to a freshly purified Ab42 monomeric sample solution. This
‘seeded’ reaction was incubated at 37uC and the aggregation was
monitored by ThT fluorescence as mentioned previously
(Figure 6). Samples of 10% solutions containing fatty acid alone
without Ab were used as controls. The control Ab42 (aggregated
in the absence of fatty acids) was able to seed with marginal
efficiency as seen by a slight increase in the rates of aggregation for
the seeded sample (Figure 6A). This was expected, as control Ab42
might not have generated enough oligomers that can act as seeds
within 48 h of incubation. Seeds containing 12–18 mers generated
in the presence of fatty acids at concentrations near their CMCs
were clearly able to augment the rates of Ab42 aggregation
compared to the control (Figure 6 B, D, F & H). Among them,
100 mM C9 and 5 mM C12 showed a dramatic increase in
aggregation rates in comparison to 50 mM C10 and 20 mM C11
(Figure 6 B, D, F & H). However, the seeds containing 4–5 mers
formed in high concentrations of fatty acids clearly failed to show
any effect on Ab aggregation rates suggesting inability of these
oligomers to seed fibril formation (Figure 6C, E, G & I). These
results suggest that the 12–18 mers may be structurally similar to
fibrils and hence, may be intermediates of the fibril formation ‘on-
pathway’. The 4–5 mers seem to be structurally dissimilar to 12–
18 mers and may represent the intermediates of an alternative,
‘off-pathway’. The inability of these aggregates to convert to fibrils
in high fatty acid concentrations as observed in Figure 2A further
supports this conclusion.
Oligomeric 4–5 mers and 12–18 mers differ in their
thermodynamic stabilities
Oligomeric Ab42 4–5 mers and 12–18 mers clearly showed a
difference in their ability to seed Ab42 fibril formation, which is
likely a consequence of dissimilarity in their structural assembly. If
it is so, we reasoned that the two species may also differ in their
thermodynamic stabilities. To assess how 4–5 mers and 12–
18 mers differ in their equilibrium stabilities, we observed the
temporal denaturation melting curves of the Ab incubations with
fatty acids using GnHCl as a denaturant. We titrated the co-
incubated samples containing 4–5 mers and 12–18 mers with
increasing concentrations of GnHCl and monitored the changes in
intrinsic tyrosine fluorescence as shown in Figure 7. The
monomeric Ab42 control did not display melting changes, as is
expected from a natively unstructured protein (&, Figure 7A, B &
C). However, aggregates formed in the presence of fatty acids at
concentrations both near (12–18 mer), and above their CMCs (4–
5 mer) showed significant fluorescence intensity that decreases to
Ab42 control levels with increasing GnHCl concentrations (# &
m; Figure 7). The first four or five data points collected at low
GnHCl concentrations were erratic, especially in high concentra-
tions of fatty acids. We think this is probably due to the slight
precipitation of fatty acids that occurs upon the addition of
GnHCl. However, at higher loadings of GnHCl, the solutions
appear to stabilize. For the same reason, it was not possible to
collect reliable data in C9 solutions, and hence this is not included.
For the other NEFA solutions, the first five data points were not
included in our curve fittings. It is evident from the data that for all
three fatty acids (C10, C11 and C12), 12–18 mers ‘melt’ earlier
than the 4–5 mers (Figure 7). The apparent melting denaturant
concentration (CM) values for the 12–18 mers (#; Figure 7)
corresponded to 1.9460.05, 0.8760.1 and 1.8660.04 M for C10,
C11 and C12 respectively. The samples containing 4–5 mers (m;
Figure 7), on the other hand, required higher concentrations of
GnHCl to denature the oligomers, with CM values corresponding
to 2.5560.03, 2.3860.06 and 3.8360.09 M for C10, C11 and
C12 respectively. The apparent melting of 4–5 mers formed at
higher concentrations of NEFAs may also be attributed to the
‘shielding’ effect of oligomers by NEFAs, which may not be
indicative of their inherent stability. In order to rule out this
possibility, we monitored similar GnHCl melts of a protein that is
unrelated to Ab, called, human granulin A (hGRN-A) as a
negative control. hGRN is a 7 kDa protein (comparable in size to
Figure 5. Western blots of Ab42 samples after 48 h of incubation in the presence of fatty acids near and above the CMC,
respectively. A) SDS-PAGE was run on a 12% bis-tris acrylamide gels in Laemmli buffer. Double arrow indicates 4–5 mers while the triple arrow
indicates 12–18 mers. The monomeric Ab42 and control (in the absence of fatty acids) are represented by M and C respectively. B) Western blots of
Ab42 samples incubated in the presence of C12 NEFA near and above the CMC run on 4–12% NuPage gels for comparison. M and C represent the
monomeric, and control Ab42 samples (lanes 1 and 2). Lanes 3 and 4 are C12 incubations with 5 and 20 mM respectively while lane 5 is the
incubation of Ab42 in 2 mM SDS as a positive control.
doi:10.1371/journal.pone.0018759.g005
‘Off-Pathway’ Ab42 Oligomers
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Upon incubation with 5 and 20 mM C12 for 48 h, melts were
preformed similar to those in Figure 7 (Figure S2). We observed
that both 5 and 20 mM C12 resulted in comparable melting
concentrations of GnHCl with only a marginal shielding effect
observed for 20 mM C12. This difference in melting concentra-
tions is much smaller than the one between 5 and 20 mM C12
incubation with Ab42 (Figure 7C) indicating thermodynamic
Figure 6. Seeding experiments with oligomers. (A–I) Ab monomer (25 mM) was incubated alone or with 10% (m/v) seed of 48 h incubated
samples of Figure 5 at 37uC and monitored by ThT fluorescence. The figures on the left and right panel represent concentration near and above the
CMCs respectively. The unseeded control (&) is same reaction as the seeded (%) one, but lacks seed.
doi:10.1371/journal.pone.0018759.g006
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part and not just the shielding effect of NEFAs. It was interesting
to observe that 4–5 mers formed in C12 appeared to be more
stable than the rest of the 4–5 mers. The denaturation
experiments collectively suggested that the 4–5 mers were more
stable than 12–18 mers, further complementing the other data
that indicated the two oligomeric species may be structurally
different.
Oligomeric 12–18 mers can be isolated
Next, we wanted to evaluate whether we could isolate 4–5 mers
and 12–18 mers and remove monomers, fibrils and possibly the
fatty acids that may be present along with them. This will not only
facilitate the exploration of the molecular features of the
oligomers, but also will determine whether the oligomers are
stable in the absence of fatty acids. To do so, we incubated 50 mM
Ab42 monomers in 5 and 20 mM C12 for 48 h to generate 4–
5 mers and 12–18 mers as shown previously in Figure 5. The
5 mM C12 samples that generated 12–18 mers were then
subjected to fractionation by SEC in Superdex-75 column as
shown in Figure 8A. The sample fractionated into void volume
and inclusion volume peaks. The fractions were then subjected to
electrophoresis and immunoblotting (Figure 8B), which indicated
the presence of 12–18 mers exclusively in the void volume peaks
(fractions 17–18) as well as in the partially included volume
(fractions 19–20), and monomers in the inclusion volume (fractions
23–25). The data clearly suggested that the 12–18 mers could be
fractionated in a fairly homogeneous form. We checked the
structural integrity of the isolated 12–18 mer by far-UV CD
(Figure 8C), which showed a well-defined b-sheet structure for the
sample in fraction 18 as compared to the random-coil for the
fractionated monomer in fraction 24. In order to determine
whether the isolated 12–18 mers were able to ‘seed’ Ab fibril
formation, we performed a ‘seeding’ experiment as described
previously. As Figure 8D shows, 10 and 20% (molar) seeds of the
isolated 12–18 mers were able to increase the rate of Ab
aggregation as observed for the oligomers prior to fractionation.
AFM images of the isolated 12–18 mers showed spherical
structures on the mica surface with a bimodal distribution of
sizes; one with average height 9.1 nm61.7 nm and a second of
19.3 nm61.0 nm (Figure 8E). Quantitation of any residual NEFA
present in the isolated 12–18 mers showed only,0.5% present
(data not shown). These result suggested that the isolated 12–
18 mers maintained their structural integrity after being subjected
to SEC. Similar attempts to isolate 4–5 mers in a similar fashion
were not successful (data not shown). We are currently in the
process of addressing this issue along with analyzing the structural
assembly of 12–18 mers that will be published later.
Discussion
Interfaces are known to have profound effect on Ab
aggregation. The data presented here provide some unique
insights into the phenomenon of interfacial aggregation in the
presence of medium-chain saturated NEFAs. The data show that
different concentrations of fatty acids seem to induce multiple
pathways of Ab42 aggregation. More importantly, the aggregation
pathways adopted by Ab appear to be dependent on the nature of
the interface (generated by the specific concentration of NEFAs),
and not the type of fatty acid used. For example, similar 12–
18 mers or 4–5 mers are generated near and above the CMC of
the fatty acid irrespective of its carbon chain length. In addition,
increasing Ab: NEFA ratios resulted in a proportional increase in
fibrils for those incubated,CMC, where 12–18 mers are formed
(Figure S3). However, the amount of 12–18 mers seem to remain
stable. Similarly, increase in Ab:NEFA ratio for incuba-
tions.CMC (4–5 mers) resulted in the formation of 12–18 mers
(Figure S2) suggesting ratios of Ab and NEFA are important in
Figure 7. Thermodynamic stabilities of the oligomers deter-
mined by GnHCl denaturation experiments. Ab42 (25 mM) was
incubated alone (&) or with NEFAs C10 (A), C11 (B) and C12 (C)under
similar conditions as those represented in Figure 2, at concentrations
near (#) and above (m) the CMCs of the fatty acids. The samples after
48 h incubations were subjected to denaturation by the addition of 6M
stock of GnHCl solution. The reactions were monitored by tyrosine
intrinsic fluorescence. Three scans were averaged and the areas under
the peaks normalized and plotted against GnHCl concentrations. The
data was fit using Boltzmann’s sigmoidal fit (Eq 2) by Origin 7.0.
doi:10.1371/journal.pone.0018759.g007
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Furthermore, the nature of the interface (micellar or otherwise)
and not just the ratio of Ab: fatty acid seems to play a major role in
dictating pathways. This is evident from the aggregation patterns
of Ab42 in the presence of 20 mM C9, C11 and C12, at constant
Ab: fatty acid ratios (Figure 2). However, the concentration of
20 mM fatty acid falls well below the CMC for C9 and near the
CMC for C11, while the same concentration falls well above the
CMC for C12 (Figure 1). Clearly, at this concentration, C9 does
not have any effect of Ab42 aggregation while C11 and C12
induce the formation of 12–18 mers and 4–5 mers respectively
(Figure 2E), indicative of the importance of CMC in Ab
interactions.
Oligomeric 12–18 mers and 4–5 mers are ‘off-pathway’
products with subtle structural differences
At concentrations near the CMC, the fatty acids were able to
induce the formation of Ab42 12–18 mers within the first 24–48 h
of incubation that were present during the rest of the 10-day
incubation period. The samples containing 12–18 mers also
displayed a ‘ThT-positive’ character and showed increased rates
of aggregation. It was difficult to establish whether the oligomeric
species themselves bound ThT or the presence of some fibrils in
these samples (Figure 4) was responsible for increased ThT
fluorescence. Nevertheless, it seems probable that the 12–18 mers
are formed in the same pathway Ab fibril formation. Evidence in
support of this comes from seeding experiments in which both
non-isolated and isolated 12–18 mers were able to accelerate Ab
fibril formation (Figures 5 and 7). However, two separate
experiments suggest 12–18 mers are formed as ‘off-pathway’
products; First, the incubations for longer periods of time (,500 h)
failed to result in the complete depletion of the 12–18 mer bands
as expected for on-pathway intermediates (Figure 9). Secondly,
known inhibitors of the ‘on-pathway’ fibril formation such as as
Rifampicin and Congo Red [33,56,57], failed to inhibit the
formation of 12–18 mers (Figure 9). Although seeding is suggestive
of intermediates being ‘on-pathway’, the ability of 12–18 mers to
seed fibril formation may indicate their structural similarity with
the on-pathway fibrils. Interestingly, isolated 12–18 mers free of
monomers and NEFAs slowly converted to fibrils over 500 h of
incubation at 37uC (Figure 9). Together, the data suggests that the
12–18 mers are trapped as ‘off-pathway’ intermediates, stabilized
Figure 8. Oligomeric 12–18 mers can be isolated and characterized. Ab42 (50 mM) was incubated with 5 mM C12 for 48 h at 37 uCt o
generate 12–18 mers. A) The sample was fractionated on a Superdex-75 SEC with a flow rate of 0.5 ml/min, Vo indicates void volume, B) Immunoblots
of the fractions, developed with Ab9 antibody indicates the separation of 12–18 mers and monomers, C) Far-UV CD spectra of the fractionated
samples, fraction 18 and 24 that show b-sheet and random coil structures respectively. and, D) seeding experiment was performed with 10% (#) and
20% (m) of fraction 18 as seeds with 25 mMA b42 monomer at 37uC Control in the absence of seeds is shown as (&) and the data was fit with Eq 1 as
in Figure 2. E) AFM image (565 mm) of fraction 18 (12–18 mer) shows largely a bimodal distribution of spherical particles.
doi:10.1371/journal.pone.0018759.g008
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18 mers), they are able associate with each other to form larger
aggregates and to eventually fibrils (Figure 9). The rate of fibril
formation is however slow, suggesting that 12–18 mers may be
kinetically trapped as ‘off-pathway’ species.
The 4–5 mers on the other hand, clearly behaved as ‘off-
pathway’ products. For the entire incubation period, samples
containing predominantly 4–5 mers (in high fatty acid concentra-
tions) did not show increase in ThT fluorescence levels. Similar to
12–18 mers, they also failed to convert to fibrils over long
incubation periods,500 h (Figure 9). In addition, 4–5 mer-
containing samples were fairly homogenous without fibrils or
any higher molecular weight species (Figure 2E and 4).
Furthermore, 4–5 mers could not ‘seed’ Ab42 fibril formation,
supporting the suggestion of their structural incompatibility to
nucleate on-pathway aggregation. Unfortunately, it was not
possible to fractionate 4–5 mers over an SEC column, as was
done for 12–18 mers, to test their seeding ability and we are
currently in the process of addressing this issue. Nevertheless, the
collective data suggest that 12–18 mers and 4–5 mers are
oligomers that are trapped (at least transiently) in a local energy
minimum, or in other words, ‘off-pathway’. It is also likely that the
fatty acids stabilize the oligomer structure in such way that they
are unable to aggregate and that the removal of fatty acid may
destabilize the oligomer. But 12–18 mers and 4–5 mers exhibit
only subtle structural differences (Figure 3, CD spectra) that are
large enough to be differentiated by ThT binding. We are
currently investigating these aspects and will be published later.
The precise nature of Ab-NEFA interactions is not known.
However, one can speculate the reasons for the observed Ab42
aggregation behavior based on our results and generate a model as
shown in Figure 10. Assuming that the non-micelle rRmicelle
transition is a concerted reaction with an equilibrium constant, KD
being equal to the CMC value, it is clear that the interaction of Ab
with fatty acids well above their CMCs is exclusively with the
micellar form (Figure 10). The anionic interface provided by the
micelle seems to accommodate 4–5 monomers of Ab42 that
interact among themselves to form oligomeric 4–5 mers. Based on
our initial thermodynamic analysis, these 4–5 mers are more
stable (may be stabilized by the micelles themselves) than the 12–
18 mers (Figure 7). Hence, it is possible that they are trapped in a
local energy minimum as ‘off-pathway’ products. The non-
micellar forms of NEFAs (,,CMC) do not seem to affect Ab42
aggregation (Figure 2). However, at concentrations near the CMC,
the dynamic equilibrium that exists during non-micelle rR
micelle transition seems to have unique effects on Ab42
aggregation as discussed above. It is possible that due to this
dynamic equilibrium, the interface formed is not well defined and
a different mode of interaction exists between Ab and the fatty
acids as shown in Figure 10. This would also mean that the 12–
18 mers may be kinetic intermediates along the ‘off pathway’ as
opposed to the 4–5 mers, which are possibly thermodynamic in
nature.
Effects of NEFAs and SDS on Ab42 aggregation are
similar yet with subtle differences
The collective data suggest that the SDS-induced Ab42
oligomer formation that was observed previously [30] can be
recapitulated with high fidelity in NEFAs, and this supports our
hypothesis that interfaces can dictate multiple Ab aggregation
pathways. However, there are some inherent differences between
the fatty acid- and SDS-induced Ab42 oligomers: (i) Ab42 was
able to form 2–4 mers at concentrations just below the CMC of
SDS (2 mM), whereas with saturated C9–C12 NEFAs, 4–5 mers
are formed only at concentrations well above their respective
CMCs; at concentrations near the CMC, NEFAs increase the
rates of Ab aggregation and form 12–18 mers; and (ii) low
concentrations of SDS (well below its CMC) increased the rates of
Ab aggregation while similar concentrations of NEFAs did not
have any effect on Ab42 oligomerization. These differences
probably suggest that the significance of the surfactant anionic
charge density in generating the interface which in turn affects Ab
aggregation pathways.
All oligomeric species need not be intermediates of the
fibril formation pathway: Physiological relevance
Several groups have focused attention on identifying and
characterizing Ab oligomers both in vitro and in vivo, which has
led to several important findings. It was widely believed that these
oligomers are intermediates along the fibril formation pathway
(on-pathway). However, the polymorphism among Ab aggregates
suggests that there may be more than one pathway. Only a
handful of reports indicate that the oligomers may not be
obligatory intermediates to fibril formation but may populate
alternate pathways from the classic nucleation-dependant one
[23,33,58,59]. It is important to understand the pathways of
Figure 9. Oligomeric 12–18 mers as well as 4–5 mers are
formed along ‘off-pathway’. All samples were electrophoresed on
4–12 % NuPage gels with MES running buffer. A) Immunoblots of
incubations of buffered 25 mMA b42 with 5 and 20 mM C12 for,500 h
at 37uC similar to Figure 2. Double and triple arrowheads indicate 4–
5 mers and 12–18 mers respectively. B) Immunoblots of fractionated
12–18 mers (9 mM) of Ab42 by SEC (Figure 8) in 20 mM TrisHCl, 50 mM
NaCl, pH 8.0 incubated at 37uC at the indicated times. C) Effect of fibril
inhibitors like Congo red (CR) & Rifampicin (Rfn) on Ab42 oligomer
formation. Lanes 1–5 show 25 mMA b42 incubations with 5 mM C12:
lane 1- with no inhibitor; lanes 2 and 3- with 6- and 8-fold molar excess
of CR; lanes 4 and 5- with 6- and 8-fold molar excess of Rfn. Lanes 6–10
show similar Ab42 incubations with 20 mM C12: lane 6- with no
inhibitor; lanes 7 and 8- with 6- and 8-fold molar excess of CR; lanes 9
and 10- with 6- and 8-fold molar excess of Rfn.
doi:10.1371/journal.pone.0018759.g009
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pathway’ products, their half-life can be significantly longer than
that of the ‘on-pathway’ oligomers, resulting in prolonged toxicity
to neuronal cells. From the data presented here, we can
hypothesize that some lipids and fatty acids may promote the
formation of oligomers as ‘off-pathway’ products, and that the
pathway may be dictated by the concentration and relative ratios
of lipid to Ab, which may be a significant aspect of Ab amyloid
biology.
The phenomenon of interfacial aggregation has been known for
quite some time and many physiological interfaces are known to
profoundly affect Ab aggregation. Amphipathic Ab peptide is
known to have strong affinity for membranes that appear to affect
the early stages of Ab aggregation significantly [14,18,60–63].
Anionic phospholipids and GM1 ganglioside-containing lipid rafts
are reported to increase the rates of Ab aggregation
[21,22,26,61,64,65]. NMR determination of the interactions
between Ab40 and phosphatidylglycerols indicated that the
interactions were largely restricted to the surface of lipids [66].
In addition to lipids, Barghorn and colleagues have reported that
oligomers generated in fatty acids such as lauric acid, oleic acid
and arachidonic acid were able to inhibit hippocampal LTP in
Tg2576 mice [32], suggesting that they are toxic to the neuronal
cells. The effect of physiological interfaces does not seem to be
limited to Ab alone. Many amyloidogenic proteins such as a-
synuclein, b2-microglobulin, apolipoprotein C-II and prions are
reported to have unique effects in the presence of interfaces
[40,45,67–70]. Recently, a bacterially expressed recombinant
prion protein, PrP converted to an infectious form, PrP
Sc that was
shown to propagate only upon binding to anionic phosphatidyl
membrane surfaces [71]. Given its physiological significance, lipid-
induced interfacial aggregation can be pathologically significant in
neurodegenerative diseases, especially with Ab aggregation in AD.
In the same context, the results discussed in this manuscript
summarize an important phenomenon of Ab amyloidogenesis,
which is as follows: It is evident that interfaces can affect Ab
aggregation in more than one way, particularly in dictating
multiple pathways. Given the mobility of cell membrane and lipid
rafts in cellular environments that may result in concentration
variations along the surface, it is possible that the ratio of Ab and
lipid components along with stoichiometry of interactions between
the two may vary. This can potentially lead to the generation of
‘off-pathway’ oligomeric products, and since such products can
have longer half-lives than ‘on-pathway’ intermediates, they may
cause prolonged and extensive damage to the neuronal cells.
Materials and Methods
Materials
Ab42 was synthesized at the Peptide Synthesis Facility at the
Mayo Clinic (Rochester, MN) using routine Fmoc chemistry.
MALDI-ToF mass spectrometry revealed.90% purity of both
peptides. SDS, bovine serum albumin, and thioflavin T were
procured from Sigma (St. Louis, MO). All fatty acids were
purchased as sodium salts from NuCheck Prep Inc (Elysian, MN).
All other chemicals were obtained from VWR Inc.
Preparation of Ab42 monomers
Lyophilized stocks of synthetic Ab42 were stored at 220uC,
desiccated. Prior to the experiments, any pre-formed aggregates
that may have been present were removed via size exclusion
chromatography (SEC) as previously reported[30]. Briefly,
223 mg of the peptide were dissolved in 0.5 ml of 30 mM
NaOH, and allowed to stand at room temperature for 15 min
before loading onto a Superdex-75 HR 10/30 size exclusion
column (SEC) (GE Life Sciences) attached to an AKTA FPLC
system (GE Healthcare, Buckinghamshire). The column was pre-
equilibrated in 20 mM Tris-HCl (pH 8.0) at 25uC and was run at
Figure 10. Schematic model of Ab42 aggregation pathways in the presence of NEFAs based on the data obtained in this study. The
square brackets indicate isolated oligomers while the question mark indicates that these parts were not explored in this study.
doi:10.1371/journal.pone.0018759.g010
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Concentrations of the purified fractions were estimated by UV-Vis
spectroscopy on a Cary 50 spectrophotometer (Varian Inc) using a
molar extinction coefficient (e) of 1490 cm
21 M
21 (www.expasy.
org) that corresponds to the single tyrosine residue within Ab42.
Peptide integrity after SEC was again confirmed by MALDI-TOF
mass spectrometry that yielded a peak corresponding to a
monoisotopic molecular mass of 4516.31 Da in a good agreement
with a calculated mass of 4514.13 Da. Monomeric Ab42 fractions
were stored at 4uC and were used within three days of purification
in all experiments to avoid the presence of pre-formed aggregation
in our reactions.
Ab aggregation reactions
All reactions and measurements were made at room temper-
ature unless otherwise noted. Reactions were initiated in
siliconized eppendorf tubes by incubating appropriate concentra-
tions of freshly purified Ab42 monomer in buffer without
agitation. Aggregation kinetic parameters were obtained by
monitoring the reaction with thioflavin T (ThT) and fitting
fluorescence data points to the sigmoidal curve in eq. 1[53] using
Origin 7.0.
F~
a
1ze
{ (t{t0:5)=b ½ 
ðEq1Þ
In this equation t is time, a and b are fixed parameters, and t0.5 is
the time to reach half-maximal thioflavin-T fluorescence. Lag
times were equal to t0.5 2 2b for each fitted curve.
Measurement of critical micelle concentration (CMC)
CMCs of fatty acids were determined using N-phenyl-1-
naphthylamine (NPN) from Sigma (St. Louis, MO) as a fluorescent
probe. Fluorescence measurements of NPN in the presence of fatty
acids were acquired at the excitation wavelength of 340 nm and
scanning emission wavelengths spanning 400–500 nm were
monitored on a Cary Eclipse spectrometer (Varian Inc.). Fatty
acid mixtures contained 0.5 mM–170 mM fatty acid along with
50 mM NaCl in 10 mM Tris buffer, pH 8.0. NPN was added to a
total concentration of 1.5 mM and the solution was incubated for
30 minutes at 37uC. The data points were fitted to obtain a linear
curve using Origin 7.0.
Polyacrylamide gel electrophoreses (PAGE) and
immunoblotting
In our experiments, we have used both 12% bis-Tris as well as
4–12% NuPage gels. Samples were dissolved in loading buffer (1 X
Laemmli buffer for 12% bis-Tris gels; MES buffer for 4–12% gels)
containing 1% SDS, applied without heating to 12% acrylamide
gels containing bis-Tris, or 4–12% NuPage gels and resolved in
Laemmli running buffer with 0.1% SDS. Dye-linked MW markers
(Blue Plus2 Prestained Standards, Invitrogen) were run in parallel
for calibration. Gels were electroblotted onto 0.45 mm Immobi-
lonH nitrocellulose membranes (BioTrace
TM NT, Life Sciences
Inc). Blots were boiled in a microwave oven in PBS for 2 min and
were blocked overnight with 1X PBS containing 5% nonfat dry
milk and probed (3–5 h) with 1:1000–1:2500 dilutions of
monoclonal antibodies Ab9, which detects amino acid residues
of Ab (1–16). Blots were then incubated with an anti-mouse
horseradish peroxide (HRP) conjugate and developed with ECL
reagent (Thermo Scientific).
Fluorescence spectroscopy
ThT fluorescence (F) was monitored in a microcuvette with a
Cary Eclipse spectrometer (Varian Inc) after 15-fold dilution of
Ab42 samples into 5 mM Tris-HCl (pH 8.0) containing 10 mM
ThT. Continuous measurements of F were taken for 1min with the
excitation and emission wavelengths fixed at 450 and 482 nm
respectively, and the excitation and emission slits set at 10 nm.
The fluorescence blanks were subtracted from the respective data
and the average F value was determined.
Atomic force microscopy (AFM)
Mica was cleaved using a razor blade and taped to a magnetic
sample holder. The mica stub was then covered with a 3-
aminopropyl-triethoxy silane (APTES) solution (500 mL APTES in
50 mL 1mM acetic acid) for 15 minutes. The APTES solution was
then decanted and the mica was rinsed with 150 mL of deionized
water, four times. After rinsing, the mica stub was dried with
compressed N2 gas and stored in a desiccator for an hour. Next,
150 mL of 0.1–0.25 mMA b sample was added to the mica and
allowed to adsorb for 20 minutes. The sample was then decanted
and the mica stub was rinsed with 150 mL of deionized water, four
times. Finally, the mica stub was dried with compressed N2 gas
and stored in a desiccator until imaging. The surface topography
of each sample was explored by imaging the peptide after it had
been adsorbed onto APTES treated freshly cleaved mica. These
images were obtained via an Agilent 5500 AFM (Agilent
Technologies) in alternating current mode using RTESP etched
silicon probes (length: 125 mm, nominal force constant: 40 N/m,
and resonance frequency: 275 kHz) (Veeco Instruments). While
under ambient environmental conditions, the scan rate was held
constant at 1 Hz. Each image (512x512 data points) was processed
using Gwyddion version 2.7 software to remove artifacts and
improve image quality by applying plane leveling, line correction
and scar removal operations. This software was also used to
extract height profiles, which allowed for the calculation of
average feature heights. Multiple areas were imaged for each
sample and while height, phase and amplitude images are
collected simultaneously, only representative amplitude images
are presented.
Circular dichroism (CD)
CD spectra were obtained in the far UV region with a Jasco
J-810 spectropolarimeter (Jasco Inc, Easton, MD). Aliquots of
samples containing Ab42 (25 mM) were placed in a 0.1 cm path-
length quartz cuvette (Hellma) and were monitored in continuous
scan mode (260–190 nm). The acquisition parameters were
50 nm/min with 8 s response time, 1 nm bandwidth and
0.1 nm data pitch, and data sets were averaged over three scans.
All data were collected in duplicate. Spectra of appropriate blanks
were subtracted from the data sets as indicated. The corrected,
averaged spectra were smoothed using the ‘means-movement’
algorithm with a convolution width of 25 using the Jasco spectra
analysis program.
Seeding experiments
Monomeric Ab42 (25 mM) was incubated alone or with
different concentrations of fatty acids in a buffer containing
50 mM NaCl and 20 mM Tris pH 8.0. After 48 hr 10% (m/v)
seeds of the incubated sample were withdrawn and mixed with
fresh monomeric Ab42 (25 mM) samples and incubated at 37uC
under quiescent condition along with a control lacking seed. The
rate of Ab42 aggregation was monitored using ThT assay. Similar
experiments were performed with isolated oligomers also.
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The thermodynamic stability of the oligomers formed in the
presence of fatty acids was determined by guanidine-HCl (GnHCl)
denaturation. Ab42 (25 mM) samples in the presence of specific
concentrations of fatty acids (to generate 12–18mers or 4–5mers)
were incubated at 37uC. Aliquots of the samples were taken after
48 h of incubation and tyrosine intrinsic fluorescence was
measured using lex 276 nm and scanning the emission spectrum
(lem) between 300–400 nm with a excitation/emission slit widths
of 10/10 nm on a Cary Eclipse fluorescence spectrometer (Varian
Inc). The sample was then subjected to denaturation by tritrating
with 6M GnHCl stock solution into the fluorescence cuvette, at
room temperature. Three scans were collected and averaged.
Control spectra were measured by adding buffer without fatty
acids to buffered 25 mMA b42 using the same volumes of GnHCl,
which were subtracted from the sample spectra. The area under
the curve of the blank-corrected spectra was plotted against the
GnHCl concentration. The data were then normalized against the
lowest and highest fluorescence intensity for the given fatty acid
concentration. Three such blank-corrected spectra were averaged
and are represented here. The resulting curve is fitted using the
following Boltzmann equation;
F~
A1{A2
1ze
(C{CM)=dC zA2 ðEq2Þ
where, A1 and A2 are constants, C is the concentration of the
denaturant and CM is the mid-point of the curve that is considered
as the concentration of ‘melting’. The data were processed using
Origin 7.0.
Supporting Information
Figure S1 Far-UV CD spectra of 25 mMA b42 incubations with
NEFAs at concentrations well below the respective CMCs; 20 mM
C9 (A), 10 mM C10 (B), 2 mM C11 (C) and 2 mM C12 (D). To
data points are shown; initial 0 h point and the final 240 h point.
Data were normalized as mentioned in Materials and Methods.
(TIF)
Figure S2 Guanidine denaturation of hGRN-A incubated with
NEFAs as a negative control. Buffered (20 mM TrisHCl, 50 mM
NaCl, pH 8.0) hGRN-A (15 mM) was incubated with 5 (#)o r
20 mM C12 (m) at 37 C.After 48 h, aliquots of the sample was
subjected to GnHCl titration (using 6 M GnHCl as stock) that was
monitored by tryptophan intrinsic fluorescence (lex=280 nm;
lem=340 nm). Data were normalized and fit using the same
calculations as mentioned in Materials and Methods.
(TIF)
Figure S3 Incubation of 5 & 20 mM C12 with varying
concentrations of Ab42 ; lane (1–4) 5 mM C12 with 12.5, 25,
50, 75 mMA b42 respectively ; lane (5–8) 20 mM C12 with 12.5,
25, 50, 75 mMA b42 respectively.
(TIF)
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